Cardiovascular risk is similar in patients with glomerulonephritis compared to other types of chronic kidney disease: a matched cohort study

por Hutton, Holly L., Levin, Adeera, Gill, Jagbir, Djurdjev, Ognjenka, Tang, Mila, Barbour, Sean J.
Publicado 2017

Screening for primary aldosteronism is underutilised in patients with chronic kidney disease

por Chauhan, Karanjeet, Schachna, Eitan, Libianto, Renata, Ryan, Jessica, Hutton, Holly, Fuller, Peter J., Wilson, Scott, Kerr, Peter G., Yang, Jun
Publicado 2022

Deletions in VANGL1 are a risk factor for antibody-mediated kidney disease

por Jiang, Simon H., Mercan, Sevcan, Papa, Ilenia, Moldovan, Max, Walters, Giles D., Koina, Mark, Fadia, Mitali, Stanley, Maurice, Lea-Henry, Tom, Cook, Amelia, Ellyard, Julia, McMorran, Brendan, Sundaram, Madhivanan, Thomson, Russell, Canete, Pablo F., Hoy, Wendy, Hutton, Holly, Srivastava, Monika, McKeon, Kathryn, de la Rúa Figueroa, Iñigo, Cervera, Ricard, Faria, Raquel, D’Alfonso, Sandra, Gatto, Mariele, Athanasopoulos, Vicki, Field, Matthew, Mathews, John, Cho, Eun, Andrews, Thomas D., Kitching, A. Richard, Cook, Matthew C., Riquelme, Marta Alarcon, Bahlo, Melanie, Vinuesa, Carola G.
Publicado 2021